Clinical trials
Withdrawn Metabolic Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Family Medicine Residency of Idaho | 1 |
| Gladwin, Mark, MD | 1 |
| Jean L. Fry | 1 |
| Oregon Health and Science University | 1 |
| Pennington Biomedical Research Center | 1 |
| Plymouth State University | 1 |
| Prism Health North Texas | 1 |
| Rockefeller University | 1 |
| SomaLogic, Inc. | 1 |
| Texas Tech University Health Sciences Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 16 |
| Insulin Resistance | 6 |
| Obesity | 5 |
| Hypertension | 4 |
| Glucose Intolerance | 3 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Body Weight Changes | 1 |
| Diabetes Mellitus, Type 1 | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.